HRP20110089T1 - Čvrsti farmaceutski pripravak koji sadrži telitromicin - Google Patents
Čvrsti farmaceutski pripravak koji sadrži telitromicin Download PDFInfo
- Publication number
- HRP20110089T1 HRP20110089T1 HR20110089T HRP20110089T HRP20110089T1 HR P20110089 T1 HRP20110089 T1 HR P20110089T1 HR 20110089 T HR20110089 T HR 20110089T HR P20110089 T HRP20110089 T HR P20110089T HR P20110089 T1 HRP20110089 T1 HR P20110089T1
- Authority
- HR
- Croatia
- Prior art keywords
- weight
- telithromycin
- proportion
- tablet according
- povidone
- Prior art date
Links
- 229960003250 telithromycin Drugs 0.000 title claims abstract 13
- LJVAJPDWBABPEJ-PNUFFHFMSA-N telithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@@H]([C@]2(OC(=O)N(CCCCN3C=C(N=C3)C=3C=NC=CC=3)[C@@H]2[C@@H](C)C(=O)[C@H](C)C[C@@]1(C)OC)C)CC)[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O LJVAJPDWBABPEJ-PNUFFHFMSA-N 0.000 title claims abstract 10
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract 7
- 239000002253 acid Substances 0.000 claims abstract 5
- 150000003839 salts Chemical class 0.000 claims abstract 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract 4
- 229920003023 plastic Polymers 0.000 claims abstract 3
- 239000004033 plastic Substances 0.000 claims abstract 3
- 239000004480 active ingredient Substances 0.000 claims abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 6
- 239000011230 binding agent Substances 0.000 claims 4
- 239000000314 lubricant Substances 0.000 claims 4
- 238000002360 preparation method Methods 0.000 claims 4
- 229920002785 Croscarmellose sodium Polymers 0.000 claims 3
- 229920003080 Povidone K 25 Polymers 0.000 claims 3
- 229920003081 Povidone K 30 Polymers 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 claims 3
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims 3
- 235000019359 magnesium stearate Nutrition 0.000 claims 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 3
- 229940100487 povidone k25 Drugs 0.000 claims 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 2
- 238000000354 decomposition reaction Methods 0.000 claims 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
- 229940069328 povidone Drugs 0.000 claims 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- 229920001531 copovidone Polymers 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 229960003943 hypromellose Drugs 0.000 claims 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
- 239000000454 talc Substances 0.000 claims 1
- 229910052623 talc Inorganic materials 0.000 claims 1
- 239000004408 titanium dioxide Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0501936A FR2882522B1 (fr) | 2005-02-25 | 2005-02-25 | Composition pharmaceutique solide comprenant de la telithromycine |
| PCT/FR2006/000411 WO2006090067A1 (fr) | 2005-02-25 | 2006-02-23 | Composition pharmaceutique solide comprenant de la telithromycine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110089T1 true HRP20110089T1 (hr) | 2011-03-31 |
Family
ID=35106715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110089T HRP20110089T1 (hr) | 2005-02-25 | 2011-02-03 | Čvrsti farmaceutski pripravak koji sadrži telitromicin |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US20080113020A1 (ko) |
| EP (1) | EP1855695B1 (ko) |
| JP (1) | JP5063368B2 (ko) |
| KR (1) | KR101346453B1 (ko) |
| CN (1) | CN101180064B (ko) |
| AR (1) | AR053144A1 (ko) |
| AT (1) | ATE486633T1 (ko) |
| AU (1) | AU2006217814B2 (ko) |
| BR (1) | BRPI0608395A2 (ko) |
| CA (1) | CA2598210A1 (ko) |
| CY (1) | CY1111129T1 (ko) |
| DE (1) | DE602006017975D1 (ko) |
| DK (1) | DK1855695T3 (ko) |
| ES (1) | ES2354906T3 (ko) |
| FR (1) | FR2882522B1 (ko) |
| HK (1) | HK1120412A1 (ko) |
| HR (1) | HRP20110089T1 (ko) |
| IL (1) | IL185251A (ko) |
| ME (1) | ME01936B (ko) |
| MX (1) | MX2007010405A (ko) |
| MY (1) | MY145394A (ko) |
| PL (1) | PL1855695T3 (ko) |
| PT (1) | PT1855695E (ko) |
| RS (1) | RS51578B (ko) |
| RU (1) | RU2371184C2 (ko) |
| SI (1) | SI1855695T1 (ko) |
| TW (1) | TWI371280B (ko) |
| UY (1) | UY29403A1 (ko) |
| WO (1) | WO2006090067A1 (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2882522B1 (fr) | 2005-02-25 | 2007-04-13 | Aventis Pharma Sa | Composition pharmaceutique solide comprenant de la telithromycine |
| CN102499936B (zh) * | 2011-12-01 | 2013-06-26 | 西北农林科技大学 | 一种复方泰利霉素纳米乳口服液及其制备方法 |
| WO2017061431A1 (ja) * | 2015-10-05 | 2017-04-13 | 富山化学工業株式会社 | ソリスロマイシンを含む錠剤 |
| MX2018010652A (es) * | 2016-01-12 | 2021-07-16 | Wockhardt Ltd | Composiciones farmaceuticas. |
| WO2020021574A1 (en) * | 2018-07-27 | 2020-01-30 | Wockhardt Limited | Pharmaceutical compositions and methods |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2719587B1 (fr) | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| US6985594B1 (en) * | 1999-06-15 | 2006-01-10 | Hearing Enhancement Co., Llc. | Voice-to-remaining audio (VRA) interactive hearing aid and auxiliary equipment |
| FR2821747B1 (fr) * | 2001-03-09 | 2004-07-02 | Ethypharm Lab Prod Ethiques | Suspension de telithromycine a gout masque |
| FR2826274B1 (fr) * | 2001-06-21 | 2003-09-26 | Aventis Pharma Sa | Formulation pharmaceutique au gout masque et son procede de preparation |
| KR100487137B1 (ko) * | 2002-07-12 | 2005-05-03 | 주식회사 하이닉스반도체 | 반도체 소자의 제조 방법 |
| WO2004009059A1 (en) * | 2002-07-19 | 2004-01-29 | Aventis Pharma S.A. | Taste masked oral composition of telithromycin |
| US20040013737A1 (en) * | 2002-07-19 | 2004-01-22 | Philippe Becourt | Taste masked oral composition of telithromycin |
| AU2003274927A1 (en) * | 2002-08-23 | 2004-03-11 | Genome Therapeutics Corporation | Methods and reagents for preventing bacteremias |
| US20040106590A1 (en) * | 2002-08-29 | 2004-06-03 | Barry Eisenstein | Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| GB0230034D0 (en) * | 2002-12-23 | 2003-01-29 | Biochemie Gmbh | Organic compounds |
| US20050037983A1 (en) * | 2003-03-11 | 2005-02-17 | Timothy Dinan | Compositions and methods for the treatment of depression and other affective disorders |
| BRPI0408999A (pt) * | 2003-04-04 | 2006-03-28 | Pharmacia Corp | comprimidos prensados de multiparticulados de liberação oral prolongada |
| FR2882522B1 (fr) | 2005-02-25 | 2007-04-13 | Aventis Pharma Sa | Composition pharmaceutique solide comprenant de la telithromycine |
-
2005
- 2005-02-25 FR FR0501936A patent/FR2882522B1/fr not_active Expired - Fee Related
-
2006
- 2006-02-20 MY MYPI20060710A patent/MY145394A/en unknown
- 2006-02-23 PT PT06725981T patent/PT1855695E/pt unknown
- 2006-02-23 SI SI200630881T patent/SI1855695T1/sl unknown
- 2006-02-23 AU AU2006217814A patent/AU2006217814B2/en not_active Ceased
- 2006-02-23 AT AT06725981T patent/ATE486633T1/de active
- 2006-02-23 DE DE602006017975T patent/DE602006017975D1/de active Active
- 2006-02-23 KR KR1020077021860A patent/KR101346453B1/ko not_active IP Right Cessation
- 2006-02-23 JP JP2007556635A patent/JP5063368B2/ja not_active Expired - Fee Related
- 2006-02-23 ES ES06725981T patent/ES2354906T3/es active Active
- 2006-02-23 DK DK06725981.2T patent/DK1855695T3/da active
- 2006-02-23 CN CN200680005962XA patent/CN101180064B/zh not_active Expired - Fee Related
- 2006-02-23 BR BRPI0608395-1A patent/BRPI0608395A2/pt not_active IP Right Cessation
- 2006-02-23 EP EP06725981A patent/EP1855695B1/fr active Active
- 2006-02-23 CA CA002598210A patent/CA2598210A1/fr not_active Abandoned
- 2006-02-23 RS RS20110038A patent/RS51578B/en unknown
- 2006-02-23 RU RU2007135367/15A patent/RU2371184C2/ru not_active IP Right Cessation
- 2006-02-23 PL PL06725981T patent/PL1855695T3/pl unknown
- 2006-02-23 AR ARP060100663A patent/AR053144A1/es unknown
- 2006-02-23 MX MX2007010405A patent/MX2007010405A/es active IP Right Grant
- 2006-02-23 WO PCT/FR2006/000411 patent/WO2006090067A1/fr active Application Filing
- 2006-02-24 UY UY29403A patent/UY29403A1/es unknown
- 2006-02-24 TW TW095106185A patent/TWI371280B/zh not_active IP Right Cessation
-
2007
- 2007-08-13 IL IL185251A patent/IL185251A/en not_active IP Right Cessation
- 2007-08-16 US US11/839,719 patent/US20080113020A1/en not_active Abandoned
-
2008
- 2008-11-06 HK HK08112195.0A patent/HK1120412A1/xx not_active IP Right Cessation
-
2011
- 2011-01-21 CY CY20111100068T patent/CY1111129T1/el unknown
- 2011-02-03 HR HR20110089T patent/HRP20110089T1/hr unknown
-
2013
- 2013-08-30 US US14/014,677 patent/US8962021B2/en not_active Expired - Fee Related
-
2016
- 2016-10-19 ME MEP-2011-213A patent/ME01936B/me unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110089T1 (hr) | Čvrsti farmaceutski pripravak koji sadrži telitromicin | |
| RS51330B (en) | STABLE PHARMACEUTICAL FORMULATIONS OF MONTELUKAST SODIUM | |
| RS53570B1 (en) | DPP IV INHIBITOR FORMULATIONS | |
| BR0213288A (pt) | Etilcelulose altamente compressìvel para formação de comprimidos | |
| TW200726467A (en) | Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation | |
| CY1112963T1 (el) | Σταθερες φαρμακευτικες συνθεσεις περιεχουσες 7-υποκατεστημενα-3,5-διυδροξυεπτανοϊκα οξεα ή 7-υποκατεστημενα-3,5-διυδροξυεπτενοϊκα οξεα | |
| JP2018507200A5 (ko) | ||
| HRP20240564T1 (hr) | Novi farmaceutski sastav | |
| MX2007013468A (es) | Composiciones que contienen tanaproget micronizado. | |
| CO5640072A2 (es) | Composiciones farmaceuticas que comprenden atorvastatina fabricada sin granulacion | |
| HRP20120085T1 (hr) | Pripravak zibotentana koji sadrži manitol i mikrokristalnu celulozu | |
| CA2569683A1 (en) | Oral antimicrobial pharmaceutical compositions | |
| RU2008135718A (ru) | Композиции клопидогреля бисульфата | |
| RU2016150178A (ru) | Твёрдая дисперсия аллисартана изопроксила и фармацевтическая композиция | |
| CA2687491A1 (en) | Extended release formulation of nevirapine | |
| MX2009003360A (es) | Formulaciones orales liofilizadas de desintegracion rapida de un antagonista del receptor de trombina. | |
| NZ600107A (en) | Formulations, salts and polymorphs of transnorsertraline and uses thereof | |
| JP2020511419A5 (ko) | ||
| CA2435714A1 (en) | Fenofibrate tablets | |
| JP2016530238A5 (ko) | ||
| JP2018530566A5 (ko) | ||
| JP4871258B2 (ja) | トラセミドとマトリックス形成ポリマーとを含む持続放出型組成物（ｐｒｏｌｏｎｇｅｄ−ｒｅｌｅａｓｅ ｃｏｍｐｏｓｉｔｉｏｎ） | |
| AU2016231883B2 (en) | Pharmaceutical compositions of dimethyl fumarate | |
| HRP20211092T1 (hr) | Farmaceutske kompozicije antagonista 5-ht6 | |
| HRP20120499T1 (hr) | Fumarat cijanoetenil dimetilfenil amino pirimidinil amino benzonitrila |